MODIFICATION TO ALKP— 510(k) K023807

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K023807 for MODIFICATION TO ALKP, Substantially Equivalent on 2002-12-26. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code CJE
Device class: Class 2
Regulation: 21 CFR 862.1050
Advisory panel: Clinical Chemistry
Date received: 2002-11-14
Decision date: 2002-12-26
Decision: Substantially Equivalent
Clearance type: Special
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CJE

K251074 — Tru Liver Health Test Panel2025-12-19
K240468 — Alkaline Phosphatase2024-10-16
K223317 — Alkaline Phosphatase22023-07-21
K191245 — Yumizen C1200 ALP, Yumizen C1200 Albumin2019-08-30
K171971 — Comprehensive Metabolic Panel, skyla Clinical Chemistry Analyzer, Minicare C300 Clinical Chemistry Analyzer2018-01-25

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.